Satisfai Health, a leading medical solutions provider specializing in artificial intelligence (AI) applications, particularly in Gastrointestinal Endoscopy, based in Vancouver, BC, has acquired an exclusive global license from the University of Augsburg and the OTH Regensburg, Technical University of Applied Sciences, in Germany. Satisfai will further develop AI software that will transform the management of Barrett’s Esophagus, critically the detection of early esophageal cancer when curable. Barrett’s is a gastrointestinal condition affecting around 150 million people globally. Terms of the transaction were not disclosed.
Author: Praveen Suthrum
Get an overview of the main issues around the risk of patient cross-contamination with reusable GI endoscopes. Also learn about the three main challenges related to reprocessing and get facts and figures from patient cross-contamination studies.
Listen to Sravanthi Parasa, M.D. as she speaks about the integration of AI for gastroenterologists and embracing the future.Listen to Sravanthi Parasa, M.D. as she speaks about the integration of AI for gastroenterologists and embracing the future.
When gastroenterologist Michelle T. Long, MD, hit a roadblock arranging a meeting to discuss a research idea with Echosens, a medical device company specializing in liver disease, she asked a senior hepatologist in her mentor-mentee match program for his help. As it turns out, that hepatologist already had a meeting scheduled with a contact at the device company for the following day. So, he connected Long to his contact and vouched for her work—a moment she says helped launch her research career. That introduction led to a research agreement with the medical device company, which funded her use of a…
The use of artificial intelligence to aid colonoscopy improved the detection of adenomas in the hands of nonexpert endoscopists by 22%, versus conventional colonoscopy, according to a study presented at the 2021 virtual Digestive Disease Week (abstract 338). The AID-2 study evaluated the benefit of incorporating a computer-aided detection (CADe) system compared with unaided conventional colonoscopy, during 660 colonoscopies performed by 10 endoscopists who had done less than 2,000 colonoscopies each. The primary outcome was adenoma detection rate (ADR).
The U.S. gastroenterology ambulatory surgery center market size is anticipated to reach USD 10.8 billion by 2026, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.91% over the forecast period. The growth can be attributed to cost-efficiency, improved patient outcomes, and patient convenience provided by the ambulatory surgery centers. In addition, factors such as rising prevalence of digestive diseases and growing geriatric population are expected to fuel the growth. Establishment and maintenance of hospitals and other healthcare settings are capital-intensive. In addition, high cost of hospitalization associated with inpatient…
Independence Blue Cross (Independence) and US Digestive Health announced that they have signed a new five-year agreement. The agreement, which went into effect January 1, 2021, demonstrates the commitment of Independence and US Digestive Health to work together to ensure that Independence members and US Digestive Health patients are receiving gastroenterology care in the most appropriate, high-quality, and cost-effective settings. “We are pleased with this new long-term agreement which will give our members access to US Digestive Health to help prevent, treat and cure digestive disorders,” said Richard L. Snyder, M.D., executive vice president of Facilitated Health Networks, and chief…
Private equity firms were the buyer in 63 percent of second-quarter deals, according to a Bass Berry & Sims report published in JDSupra. Eleven ASC leaders spoke with Becker’s about how they think private equity will shift the ASC industry.
Capital Digestive Care (CDC) has finalized its partnership with Gastrointestinal & Liver Specialists of Tidewater, PLLC (GLST), continuing its growth as the largest private gastroenterology (GI) practice in the Mid-Atlantic Region. “Our goal for growth is to partner with highly-respected practices like GLST that share our values and our desire to provide opportunities for private practices to remain independent,” said Dr. Michael Weinstein, President & CEO of CDC. “Together, our groups will be stronger and better equipped to provide lower-cost, high-quality GI care within the Mid-Atlantic region.”
World’s best specialized hospitals 2022- GastroenterologyAs part of Newsweek’s long standing commitment to cover all aspects of health, we’ve again partnered with global research firm Statista to rank the world’s best specialized hospitals. Last year, we looked at the best facilities in six specialities: cardiology, oncology, endocrinology, neurology, gastroenterology and orthopedics. This year we are proud to expand that to ten specialities. The ranking features the top 250 hospitals for cardiology and oncology, the top 150 for cardiac surgery and pediatrics and the top 125 each in endocrinology, gastroenterology, orthopedics, neurology, neurosurgery and pulmonology.